News Feed Item

The Zacks Analyst Blog Highlights:Stratasys, 3D Systems, ExOne, Voxeljet and Alexion Pharmaceuticals

CHICAGO, Jan. 17, 2014 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Stratasys (Nasdaq:SSYS-Free Report), 3D Systems (NYSE:DDD-Free Report), ExOne Company (Nasdaq:XONE-Free Report), Voxeljet (NYSE:VJET-Free Report) and Alexion Pharmaceuticals, Inc. (Nasdaq:ALXN-Free Report).

(Logo: http://photos.prnewswire.com/prnh/20101027/ZIRLOGO)

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

Here are highlights from Thursday's Analyst Blog:

3D Printing Stocks Decline

The stupendous run of the 3D printing solution providers such as Stratasys (Nasdaq:SSYS-Free Report), 3D Systems (NYSE:DDD-Free Report), The ExOne Company (Nasdaq:XONE-Free Report) in the previous year came to an abrupt halt after some of them provided lower-than-expected guidance.

In 2013, Stratasys, 3D systems and ExOne generated returns of 45.4%, 115.1% and 114.4%, respectively, compared to a decline of 8.3%, 4.7% and 9.1% in 2014, year-to-date. Another recently-listed 3D printing company Voxeljet (NYSE:VJET-Free Report) was down 5.4% year-to-date.

The major sell-off took place on Tuesday as ExOne lowered its fiscal 2013 revenue guidance and Stratasys provided a lower-than-expected fiscal 2014 forecast. Panic set in and almost all 3D printing stocks were affected.

Stratasys' 2014 guidance indicated that operating expenses would increase significantly due to the incremental investments in sales & marketing and research & development. Moreover, Stratasys expects second-half fiscal 2014 non-GAAP net income to be governed by the rate of adoption of its new products and changing schedules of operating expenses. 

Encouragingly, Stratasys expects fiscal 2014 revenues to range between $660 million–$680 million, higher than the fiscal 2013 revenue forecast of $470 million to $490 million. Additionally, the company expects strong organic revenues. Despite these optimistic forecasts, the company's stock was downgraded to a Zacks Rank #5 (Strong Sell). This when accompanied by a 0.00% Earnings ESP does not indicate a favorable forecast for the current quarter.

Another stock that is in the news is ExOne which lowered its FY13 revenue guidance to a range of $40 million to $42 million from $48 million on account of deferment of machine sales to 2014. However, the company remained positive on organic top-line growth which is expected to be in the range of 40% to 50%.

In the trailing four quarters, ExOne posted an average 14.3% positive earnings surprise. However, for the current quarter, the company's Zacks Rank #3 (Hold) and Zacks Earnings ESP of 0.00% makes surprise prediction difficult.

The other two stocks, 3D Systems and Voxeljet, carry a Zacks Rank # 3 (Hold) and a Zacks Earnings ESP of 0.00%. Thus, we are taking a wait-and-see approach to the current quarter as regards these 3D printing stocks.

As such the 3D printing companies operate within a high-cost structure and any sort of disruption in the top line is likely to impact their overall results. Moreover, 3D printing is a relatively new concept and is likely to take time to gain popularity.

Nonetheless, the 3D printing market presents a favorable long-term opportunity as a large number of engineers, designers, architects and entrepreneurs are resorting to 3D solutions for their primary designing and product modeling. We therefore think that the adoption rate and cost control measures will be important factors determining the fortune of companies in this segment.

Prospects Bright at Alexion Pharma

Alexion Pharmaceuticals, Inc. (Nasdaq:ALXN-Free Report) said at the JPMorgan Healthcare Conference that it is on track to deliver 36% and 41% year-over-year growth in revenues and earnings respectively in 2013.  The revenue growth is attributable to strong sales of the biopharmaceutical company's sole marketed product Soliris. Soliris is available for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).

Alexion Pharma expects 2013 revenues in the range of $1.520–$1.530 billion. The company expects adjusted earnings for 2013 in the range of $3.02 to $3.04 per share. The company will provide detailed guidance for 2014 at its fourth quarter 2013 conference call later this month.

Alexion Pharma is expecting six product approvals within the time period of 2014 to 2018 including asfotase alfa (hypophosphatasia), ALXN 1101 (MoCD type A) and Soliris' label expansion. Asfotase alfa is expected to be approved by year end. This will reduce the company's dependence on Soliris for growth.

In a bid to expand, Alexion Pharma inked a deal with the privately held Moderna Therapeutics for the discovery and development of messenger ribo nucleic acid (mRNA) therapeutics to treat patients suffering from rare diseases. The drug discovery platform can expedite the development and manufacture of candidates for treating patients with rare diseases. Under the terms of the deal, Alexion will make an upfront payment of $100 million to Moderna for purchasing 10 product options to develop and commercialize therapies utilizing the mRNA platform. Alexion pharma, which has made a $25 million preferred equity investment in Moderna, will have to make milestone and royalty payments to the latter if situation arises.

We expect Alexion to deliver impressive fourth quarter 2013 revenues driven by strong Soliris sales in the PNH and aHUS indications.

Alexion Pharma carries a Zacks Rank #3 (Hold).

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today.

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros.  In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros.

Get the full Report on SSYS - FREE

Get the full Report on DDD - FREE

Get the full Report on XONE - FREE

Get the full Report on VJET - FREE

Get the full Report on ALXN - FREE

Follow us on Twitter: http://twitter.com/zacksresearch

Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
[email protected]

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

SOURCE Zacks Investment Research, Inc.

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
SYS-CON Events announced today that Niagara Networks will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Niagara Networks offers the highest port-density systems, and the most complete Next-Generation Network Visibility systems including Network Packet Brokers, Bypass Switches, and Network TAPs.
SYS-CON Events announced today that Embotics, the cloud automation company, will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Embotics is the cloud automation company for IT organizations and service providers that need to improve provisioning or enable self-service capabilities. With a relentless focus on delivering a premier user experience and unmatched customer support, Embotics is the fas...
In an era of historic innovation fueled by unprecedented access to data and technology, the low cost and risk of entering new markets has leveled the playing field for business. Today, any ambitious innovator can easily introduce a new application or product that can reinvent business models and transform the client experience. In their Day 2 Keynote at 19th Cloud Expo, Mercer Rowe, IBM Vice President of Strategic Alliances, and Raejeanne Skillern, Intel Vice President of Data Center Group and ...
SYS-CON Events announced today that StarNet Communications will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. StarNet Communications’ FastX is the industry first cloud-based remote X Windows emulator. Using standard Web browsers (FireFox, Chrome, Safari, etc.) users from around the world gain highly secure access to applications and data hosted on Linux-based servers in a central data center. ...
Virgil consists of an open-source encryption library, which implements Cryptographic Message Syntax (CMS) and Elliptic Curve Integrated Encryption Scheme (ECIES) (including RSA schema), a Key Management API, and a cloud-based Key Management Service (Virgil Keys). The Virgil Keys Service consists of a public key service and a private key escrow service. 

SYS-CON Events announced today that Cemware will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Use MATLAB functions by just visiting website mathfreeon.com. MATLAB compatible, freely usable, online platform services. As of October 2016, 80,000 users from 180 countries are enjoying our platform service.
Data is the fuel that drives the machine learning algorithmic engines and ultimately provides the business value. In his session at Cloud Expo, Ed Featherston, a director and senior enterprise architect at Collaborative Consulting, will discuss the key considerations around quality, volume, timeliness, and pedigree that must be dealt with in order to properly fuel that engine.
All clouds are not equal. To succeed in a DevOps context, organizations should plan to develop/deploy apps across a choice of on-premise and public clouds simultaneously depending on the business needs. This is where the concept of the Lean Cloud comes in - resting on the idea that you often need to relocate your app modules over their life cycles for both innovation and operational efficiency in the cloud. In his session at @DevOpsSummit at19th Cloud Expo, Valentin (Val) Bercovici, CTO of So...
More and more brands have jumped on the IoT bandwagon. We have an excess of wearables – activity trackers, smartwatches, smart glasses and sneakers, and more that track seemingly endless datapoints. However, most consumers have no idea what “IoT” means. Creating more wearables that track data shouldn't be the aim of brands; delivering meaningful, tangible relevance to their users should be. We're in a period in which the IoT pendulum is still swinging. Initially, it swung toward "smart for smar...
SYS-CON Events announced today that eCube Systems, the leading provider of modern development tools and best practices for Continuous Integration on OpenVMS, will exhibit at SYS-CON's @DevOpsSummit at Cloud Expo New York, which will take place on June 7-9, 2016, at the Javits Center in New York City, NY. eCube Systems offers a family of middleware products and development tools that maximize return on technology investment by leveraging existing technical equity to meet evolving business needs. ...
Fifty billion connected devices and still no winning protocols standards. HTTP, WebSockets, MQTT, and CoAP seem to be leading in the IoT protocol race at the moment but many more protocols are getting introduced on a regular basis. Each protocol has its pros and cons depending on the nature of the communications. Does there really need to be only one protocol to rule them all? Of course not. In his session at @ThingsExpo, Chris Matthieu, co-founder and CTO of Octoblu, walk you through how Oct...
Fact is, enterprises have significant legacy voice infrastructure that’s costly to replace with pure IP solutions. How can we bring this analog infrastructure into our shiny new cloud applications? There are proven methods to bind both legacy voice applications and traditional PSTN audio into cloud-based applications and services at a carrier scale. Some of the most successful implementations leverage WebRTC, WebSockets, SIP and other open source technologies. In his session at @ThingsExpo, Da...
So you think you are a DevOps warrior, huh? Put your money (not really, it’s free) where your metrics are and prove it by taking The Ultimate DevOps Geek Quiz Challenge, sponsored by DevOps Summit. Battle through the set of tough questions created by industry thought leaders to earn your bragging rights and win some cool prizes.
In past @ThingsExpo presentations, Joseph di Paolantonio has explored how various Internet of Things (IoT) and data management and analytics (DMA) solution spaces will come together as sensor analytics ecosystems. This year, in his session at @ThingsExpo, Joseph di Paolantonio from DataArchon, will be adding the numerous Transportation areas, from autonomous vehicles to “Uber for containers.” While IoT data in any one area of Transportation will have a huge impact in that area, combining sensor...
The Internet of Things (IoT), in all its myriad manifestations, has great potential. Much of that potential comes from the evolving data management and analytic (DMA) technologies and processes that allow us to gain insight from all of the IoT data that can be generated and gathered. This potential may never be met as those data sets are tied to specific industry verticals and single markets, with no clear way to use IoT data and sensor analytics to fulfill the hype being given the IoT today.